「more海外」の検索結果
36件：1～5件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
細菌性外眼部感染症分離株の抗菌薬に対する感受性動向（2019，2023年の比較） 秦野 寛1、水田 藍2 坂本 祐一郎2 末信 敏秀2 1 ルミネはたの眼科 2 千寿製薬株式会社 信頼性保証本部 医薬情報企画部 臨床眼科79（3）:346-354,2025 Enhancement of therapeutic efficacy of Brinzolamide for Glaucoma by nan
http://www.senju.co.jp/english/rd/thesis/ -
发表论文 | 研究与开发 | 千寿制药株式会社
細菌性外眼部感染症分離株の抗菌薬に対する感受性動向（2019，2023年の比較） 秦野 寛1、水田 藍2 坂本 祐一郎2 末信 敏秀2 1 ルミネはたの眼科 2 千寿製薬株式会社 信頼性保証本部 医薬情報企画部 臨床眼科79（3）:346-354,2025 Enhancement of therapeutic efficacy of Brinzolamide for Glaucoma by nan
http://www.senju.co.jp/chinese/rd/thesis/ -
Business Activities | About Senju | SENJU Pharmaceutical
Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph
http://www.senju.co.jp/english/about/business/ -
General Announcement: September 7, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of “Smart MIEr” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of
https://www.senju.co.jp/sites/default/files/content_news/2023-09/ENG_20230907_0.pdf -
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a
http://www.senju.co.jp/english/about/message.html